Tau Protein Linked to Mitochondrial Reverse Electron Transport in Preclinical Models
The results of a preclinical study demonstrated that phosphorylated tau enters mitochondria and initiates a vicious cycle of pathological events that trigger reverse electron transport. The post Tau Protein Linked to Mitochondrial Reverse Electron Transport in Preclinical Models appeared first on GEN - Genetic Engineering and Biotechnology News .
A recent study by researchers at Stanford University School of Medicine and the University of California, San Francisco has discovered that the protein tau, previously linked to neurodegenerative disorders such as Alzheimer's disease, may actually cause these disorders through a novel mechanism. The study found that phosphorylated tau can enter mitochondria, interfering with the electron transport chain and triggering reverse electron transport, leading to further deterioration of mitochondrial function.
This discovery suggests that RET may serve as a common pathogenic mechanism linking tau abnormalities to mitochondrial dysfunction across various diseases, potentially offering new therapeutic interventions for tauopathies.
Brief written by urgent.news from GEN Biotechnology's own syndicated text. Machine-written — it may contain errors, so check the original before relying on it.
